Farah Champsi, Director at Kite Pharma, Inc. (KITE), sold 664,102 shares at $61.22 ($41.4M) on 2015-06-30, disclosed to the SEC on 2015-07-02.
Open-market sale of $41.4M KITE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.22 | 191,798 | $11.7M | 28.4% |
| 2 | $62.14 | 113,047 | $7.0M | 17.0% |
| 3 | $63.01 | 358,757 | $22.6M | 54.6% |
| 4 | $63.82 | 500 | $32K | 0.1% |
| Total | $62.35 avg | 664,102 | $41.4M | 100% |
| Filing → |
| KITE | SELL | 2017-04-26 | $20.5M | — | Filing → |
| KITE | SELL | 2017-04-17 | $19.0M | — | Filing → |
| CMRX | SELL | 2013-10-23 | $6.9M | — | Filing → |